Illinois General Assembly - Full Text of HB1248
Illinois General Assembly

Previous General Assemblies

Full Text of HB1248  95th General Assembly

HB1248 95TH GENERAL ASSEMBLY


 


 
95TH GENERAL ASSEMBLY
State of Illinois
2007 and 2008
HB1248

 

Introduced 2/15/2007, by Rep. Elizabeth Coulson

 

SYNOPSIS AS INTRODUCED:
 
225 ILCS 85/22   from Ch. 111, par. 4142
225 ILCS 85/22b new

    Amends the Pharmacy Practice Act of 1987. Provides that prior to dispensing a prescription, a pharmacist must present the patient or a person legally authorized to make decisions for the patient with the option of having the symptom or purpose for the medication disclosed on the prescription label, and that if the patient or person legally authorized to make decisions for the patient chooses to have the symptom or purpose for the medication disclosed on the label, the pharmacist must specify the symptom or purpose of the medication in the prescription order and the prescription label must contain that symptom or purpose.


LRB095 06528 RAS 26630 b

FISCAL NOTE ACT MAY APPLY

 

 

A BILL FOR

 

HB1248 LRB095 06528 RAS 26630 b

1     AN ACT concerning regulation.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 5. The Pharmacy Practice Act of 1987 is amended by
5 changing Section 22 and by adding Section 22b as follows:
 
6     (225 ILCS 85/22)  (from Ch. 111, par. 4142)
7     (Section scheduled to be repealed on January 1, 2008)
8     Sec. 22. Except only in the case of a drug, medicine or
9 poison which is lawfully sold or dispensed, at retail, in the
10 original and unbroken package of the manufacturer, packer, or
11 distributor thereof, and which package bears the original label
12 thereon showing the name and address of the manufacturer,
13 packer, or distributor thereof, and the name of the drug,
14 medicine, or poison therein contained, and the directions for
15 its use, no person shall sell or dispense, at retail, any drug,
16 medicine, or poison, without affixing to the box, bottle,
17 vessel, or package containing the same, a label bearing the
18 name of the article distinctly shown, and the directions for
19 its use, with the name and address of the pharmacy wherein the
20 same is sold or dispensed. However, in the case of a drug,
21 medicine, or poison which is sold or dispensed pursuant to a
22 prescription of a physician licensed to practice medicine in
23 all of its branches, licensed dentist, licensed veterinarian,

 

 

HB1248 - 2 - LRB095 06528 RAS 26630 b

1 licensed podiatrist, or therapeutically or diagnostically
2 certified optometrist authorized by law to prescribe drugs or
3 medicines or poisons, the label affixed to the box, bottle,
4 vessel, or package containing the same shall show: (a) the name
5 and address of the pharmacy wherein the same is sold or
6 dispensed; (b) the name or initials of the person, authorized
7 to practice pharmacy under the provisions of this Act, selling
8 or dispensing the same, (c) the date on which such prescription
9 was filled; (d) the name of the patient; (e) the serial number
10 of such prescription as filed in the prescription files; (f)
11 the last name of the practitioner who prescribed such
12 prescriptions; (g) the directions for use thereof as contained
13 in such prescription; and (h) the proprietary name or names or
14 the established name or names of the drugs, the dosage and
15 quantity, except as otherwise authorized by regulation of the
16 Department; and (i) the symptom or purpose for which the drug
17 is being prescribed if the prescription order specifies the
18 symptom or purpose as provided for under Section 22b of this
19 Act. The Department shall establish rules governing labeling in
20 Division II and Division III pharmacies.
21 (Source: P.A. 92-880, eff. 1-1-04.)
 
22     (225 ILCS 85/22b new)
23     Sec. 22b. Statement of symptom or purpose on prescription
24 label.
25     (a) The General Assembly finds that by authorizing

 

 

HB1248 - 3 - LRB095 06528 RAS 26630 b

1 pharmacists to print the symptom or purpose of medications on
2 prescription labels, possible medication errors may be
3 avoided.
4     (b) Prior to dispensing a prescription, a pharmacist must
5 present the patient or a person legally authorized to make
6 decisions for the patient with the option of having the symptom
7 or purpose for the medication disclosed on the prescription
8 label. If the patient or person legally authorized to make
9 decisions for the patient chooses to have the symptom or
10 purpose for the medication disclosed on the label, the
11 pharmacist must specify the symptom or purpose of the
12 medication in the prescription order.